Portal stent with endovascular brachytherapy improves the efficacy of TACE for hepatocellular carcinoma with main portal vein tumor thrombus.

MLA

Li, Tian, et al. “Portal Stent with Endovascular Brachytherapy Improves the Efficacy of TACE for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus.” Hepatobiliary & Pancreatic Diseases International : HBPD INT, vol. 19, no. 2, Apr. 2020, pp. 187–90. EBSCOhost, https://doi.org/10.1016/j.hbpd.2019.10.005.

APA

Li, T., Liu, C., He, J.-T., Sui, K.-D., Zhang, Z.-B., Hong, D., Su, H.-Y., & Shao, H.-B. (2020). Portal stent with endovascular brachytherapy improves the efficacy of TACE for hepatocellular carcinoma with main portal vein tumor thrombus. Hepatobiliary & Pancreatic Diseases International : HBPD INT, 19(2), 187–190. https://doi.org/10.1016/j.hbpd.2019.10.005

Chicago

Li, Tian, Chong Liu, Jin-Tong He, Kai-Da Sui, Zhou-Bo Zhang, Duo Hong, Hong-Ying Su, and Hai-Bo Shao. 2020. “Portal Stent with Endovascular Brachytherapy Improves the Efficacy of TACE for Hepatocellular Carcinoma with Main Portal Vein Tumor Thrombus.” Hepatobiliary & Pancreatic Diseases International : HBPD INT 19 (2): 187–90. doi:10.1016/j.hbpd.2019.10.005.